Research and Markets: China Hospital Industry Development and Investment Report, 2012-2015
<0> Research and MarketsLaura Wood, Senior Manager.U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Sector: </0>
() has announced the addition of the report to their offering.
China hospital industry has maintained stable growth in recent years, thanks to the market demand stimulus and stable influx of national investment. As of late 2011, China had a total of 21,979 hospitals, with the AAGR of 2.7% during 2005-2011. In particular, the proportion of non-public hospitals grew to 39.4%. In 2011, the revenue of China hospital industry totaled RMB1.2451 trillion, with the CAGR as high as 19.7%, while the gross margin was no more than 3.8%.
In recent years, Chinese government has unveiled a series of favorable policies to boost the reform of public hospitals, encourage and guide social capitals to rush into hospital industry. This move resulted in further maturity of investment operation mode of China hospital industry. Since 2010, privately-owned hospitals including Hong Kong Phoenix International Investment Group, YMCI, SL PHARM, Xi'an Kaiyuan Investment Group Company Limited and Jinling Pharmaceutical Company Limited have been restructured through trusteeship and M&A by public hospitals, while foreign enterprises have run their business in China via joint business, joint stock and joint venture, with orientation to Chinese top-grade medical market. Cases in point include United Family Hospital and ParkwayHealth.
At present, the specialized hospitals in China are much favored in the marketization trend and little exposed to policy risk, thus, they are one of highlights when it comes to social capital investment. In 2011, the number of specialized hospitals in China surged from 2,682 in 2005 to 4,283, among which privately-owned ones accounting for 59.4%. And the revenue generated by the specialized hospitals amounted to RMB139.1bilion, with the CAGR in 2005-2011 reached 22.2% while the average gross margin realized 12.1%. In particular, the gross margin generated by ophthalmic hospitals and Cosmetic hospitals claimed 14.7% and 12.8%, respectively. In 2011, the gross margin of Aier Eye Hospital Group, TC Medical, and Mayinglong Pharm, the leading privately-run specialized hospitals in China, reported 55.3%, 47.2% and 39.4%, respectively.
1. Overview of China Hospital Industry
1.3 Industry Chain
2. Overview of China Hospital Market
2.1 Hospital Statistics
2.3 Profit Level
2.4 Medical Service
2.5 Competition Pattern
3. Current Development of Specialized Hospitals in China
3.2 Status Quo of Specialized Hospitals of All Kinds
4. Development Forecast of China Hospital Industry
4.1 Status Quo of China Medical Insurance
4.2 Urbanization Bolsters Development of the Hospital Industry
5. Investment in China Hospital Industry
5.1 Policy Environment Becomes Warm
5.2 Competitiveness of Privately-Owned Hospitals
5.3 Investment Opportunities of Social Capital
5.4 Development Direction and Operation Mode of Foreign Hospitals
6. Major Privately-Owned Hospitals in China
- Aier Eye Hospital Group
- TC Medical
- Mayinglong Pharm
- Shanghai Fosun Pharmaceutical (Group)
- Jinling Pharmaceutical Company Limited
- Shinva Medical
- Xi'an Kaiyuan Investment Group Company Limited
- Inner Mongolia Free Han & Mongolia Pharmaceutical Co.
- Wuhan Jianmin Pharmaceutical Groups Corp.
- CMS Holdings
- United Family Hospital